Medicare Enrolled
Dr. Ratan Ahuja, MD FACC
Cardiovascular Disease · Orange City, FL
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ahuja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahuja? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ahuja
Dr. Ratan Ahuja is a cardiovascular disease in Orange City, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ahuja performed 15,753 Medicare services across 5,420 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ahuja received a total of $24,377 from 62 pharmaceutical and/or device companies across 412 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahuja is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in FL$ $24,377 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,753
Medicare services
Top 3% in FL for cardiovascular disease
5,420
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~829 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 4,908 | $0 | $2 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 2,436 | $0 | $10 |
| Office visit, established patient (30-39 min) | 1,426 | $94 | $353 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,133 | $43 | $220 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 774 | $87 | $1,355 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 456 | $54 | $405 |
| Echocardiogram, transthoracic | 445 | $145 | $1,059 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 387 | $331 | $1,500 |
| Hospital follow-up visit, high complexity | 268 | $94 | $361 |
| Infusion into a vein for hydration, each additional hour | 238 | $10 | $60 |
| Office visit, established patient, complex (40-54 min) | 220 | $136 | $479 |
| Heart muscle strain imaging | 202 | $28 | $160 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 189 | $197 | $1,012 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 171 | $9 | $45 |
| Electrocardiogram (EKG), 12-lead | 149 | $11 | $96 |
| Hospital follow-up visit, moderate complexity | 148 | $63 | $253 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 140 | $0 | $10 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 129 | $313 | $1,600 |
| Ultrasound of both sides of head and neck blood flow | 124 | $133 | $696 |
| Initial hospital admission, high complexity | 120 | $137 | $690 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 106 | $16 | $100 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 105 | $7 | $60 |
| New patient office visit (45-59 min) | 102 | $118 | $550 |
| Ultrasonic guidance for blood vessel access | 88 | $30 | $138 |
| Remote pacemaker/defibrillator monitoring, 90 days | 82 | $16 | $138 |
| Programming of dual lead pacemaker system | 72 | $53 | $260 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 71 | $140 | $746 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 69 | $38 | $205 |
| Ultrasound of leg arteries or artery grafts | 66 | $182 | $721 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 64 | $2,093 | $11,000 |
| Nuclear medicine study of heart muscle blood flow by pet | 64 | $139 | $710 |
| Unclassified drugs | 62 | $11 | $52 |
| Remote pacemaker monitoring, 90 days | 58 | $22 | $148 |
| Infusion into a vein for hydration, 31-60 minutes | 53 | $25 | $225 |
| Injection of drug or substance into vein | 53 | $28 | $250 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 53 | $1 | $5 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 41 | $25 | $100 |
| Review by radiologist of both arms or legs arteries image | 39 | $128 | $1,871 |
| Injection of additional new drug or substance into vein | 36 | $12 | $105 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 35 | $873 | $7,789 |
| Injection of drug or substance into artery | 34 | $14 | $103 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 33 | $22 | $265 |
| Review by radiologist of abdominal aorta image | 30 | $99 | $1,788 |
| Programming of multiple lead implantable defibrillator system | 29 | $81 | $402 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 27 | $40 | $170 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 24 | $20 | $103 |
| Insertion of needle or tube into artery of arm or leg | 23 | $195 | $2,029 |
| Evaluation of implantable heart and blood vessel monitoring system | 21 | $36 | $120 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 20 | $725 | $5,390 |
| New patient office visit (30-44 min) | 19 | $88 | $361 |
| Review by radiologist of arm or leg artery image | 17 | $118 | $1,814 |
| Programming of dual lead implantable defibrillator system | 16 | $57 | $345 |
| Cardiac catheterization | 14 | $744 | $4,000 |
| Removal of plaque in arteries of leg | 13 | $6,654 | $30,000 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $15 | $105 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $10 | $60 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $56 | $262 |
| Office visit, established patient (20-29 min) | 12 | $68 | $233 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.1% high complexity
64.0% medium
27.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,377
Total received (2018-2024)
Avg $3,482/year across 7 years
Top 12% in FL for cardiovascular disease
62
Companies
412
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,240 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$138 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,948
2023$4,184
2022$1,534
2021$1,277
2020$1,725
2019$6,726
2018$4,983
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Cardiovascular Systems Inc.
$4,601
ABIOMED
$3,503
Abbott Laboratories
$3,288
Philips Electronics North America Corporation
$3,253
Penumbra, Inc.
$1,263
Medtronic, Inc.
$1,240
Janssen Pharmaceuticals, Inc
$1,061
Bard Peripheral Vascular, Inc.
$697
CVRx, Inc.
$625
Novartis Pharmaceuticals Corporation
$558
Cook Medical LLC
$418
GlaxoSmithKline, LLC.
$309
Kestra Medical Technology Services, Inc.
$304
Boehringer Ingelheim Pharmaceuticals, Inc.
$294
AngioDynamics, Inc.
$259
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$178
BIOTRONIK INC.
$159
Amgen Inc.
$139
Medtronic Vascular, Inc.
$138
Edwards Lifesciences Corporation
$126
Tactile Systems Technology Inc
$125
Mallinckrodt Hospital Products Inc.
$116
JAZZ PHARMACEUTICALS INC.
$110
Roche Diagnostics Corporation
$100
E.R. Squibb & Sons, L.L.C.
$92
Bayer HealthCare Pharmaceuticals Inc.
$91
Merck Sharp & Dohme LLC
$85
Jazz Pharmaceuticals Inc.
$84
Allergan Inc.
$78
Harmony Biosciences LLC
$75
Bardy Diagnostics, Inc.
$74
Mylan Specialty L.P.
$71
Pulmonx Corporation
$64
PFIZER INC.
$56
HARMONY BIOSCIENCES LLC
$54
AstraZeneca Pharmaceuticals LP
$50
Merck Sharp & Dohme Corporation
$44
BOSTON SCIENTIFIC CORPORATION
$42
Esperion Therapeutics, Inc.
$38
Inari Medical, Inc.
$35
Boston Scientific Corporation
$35
Electromed, Inc.
$34
Sunovion Pharmaceuticals Inc.
$33
Chiesi USA, Inc.
$32
Terumo Medical Corporation
$32
MEDICOMP INC
$26
Acist Medical Systems, Inc.
$26
Lexicon Pharmaceuticals, Inc.
$25
Alnylam Pharmaceuticals Inc.
$23
Impulse Dynamics (USA) Inc.
$21
Braemar Manufacturing, LLC
$20
Philips North America LLC
$19
Novo Nordisk Inc
$18
AbbVie Inc.
$18
Baxter Healthcare
$17
SCPHARMACEUTICALS INC.
$15
United Therapeutics Corporation
$15
Advanced Respiratory, Inc
$14
Teva Pharmaceuticals USA, Inc.
$14
Arrow International, Inc.
$13
Actelion Pharmaceuticals US, Inc.
$13
Shockwave Medical, Inc
$12
Top 3 companies account for 46.7% of total payments
Associated products mentioned in payments ›
(4067) Tack Endo Sys BTK · (6554) Periph Vasc Undiv · (7999) SRC Undivided · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · AVYCAZ · Adempas · Assure WCD · BELSOMRA · BREO · Barostim Neo System · CAMZYOS · CD cobas Reagents · CHANTIX · CHARTIS CATHETER · CONFIRM RX · COOK · COOK MEDICAL AAA · CVI Consumables · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Catheter - Turnpike · ClosureFast · Confirm Rx · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · ELIQUIS · ENTRESTO · ESPRIT · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FORTIFY ASSURA · FUROSCIX · GENERAL - VASCULAR INTERVENTION · GIVLAARI · Hillrom - Life 2000 Ventilation System · IGT D Peripheral · IGT Devices Und · IGT_D Peripheral · IMFINZI · Image Guided Therapy Devices _ Peripheral · Impella · Indigo · Inpefa · JARDIANCE · KENGREAL · LEQVIO · LONHALA MAGNAIR · LUX DX · Life 2000 Ventilation System · LifeVest · MetaCross · NEXLETOL · Navicross · OFEV · OPTIMIZER · ORENITRAM · Ozempic · Peripheral Orbital Atherectomy System · QUADRA ASSURA · Quadra Assura CRT Defibrillator · ROSEN · Repatha · Reveal LINQ · S · SMARTVEST · SUNOSI · SUPERA · SilverHawk · TELEPATCH CARDIAC MONITOR · TRELEGY ELLIPTA · TURBOHAWK · Turbo Elite · TurboHawk · UPTRAVI · Unify Assura CRT Defibrillator · VENASEAL · VERQUVO · VYNDAMAX · Vascular Lithotripsy · Venclose Maven Catheter · Visions PV .035 · WAKIX · WALLSTENT · WATCHMAN FLX · Wakix · XARELTO · XYWAV · Xyrem · YUPELRI · ZILVER PTX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $155 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
67
Per 100K population
11.8
County median income
$66,581
Nearest hospital
ADVENTHEALTH FISH MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ahuja is a cardiac imaging specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (low-engagement, top 12%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ahuja experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Ahuja performed 4,908 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ahuja receive payments from pharmaceutical companies?
Yes. Dr. Ahuja received a total of $24,377 from 62 companies across 412 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahuja's costs compare to other cardiovascular diseases in Orange City?
Dr. Ahuja's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahuja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Orange City
Browse cardiovascular diseases in Orange City ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology